Penumbra, Inc. (PEN)
338.00
+1.79
(+0.53%)
USD |
NYSE |
Mar 17, 16:00
342.00
+4.00
(+1.18%)
Pre-Market: 07:47
Penumbra EPS Diluted (Quarterly) : 1.202 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Revvity, Inc. | 0.8708 |
| Rapt Therapeutics, Inc. (DELISTED) | -0.652 |
| Abbott Laboratories | 1.030 |
| Alphatec Holdings, Inc. | -0.1428 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 47.34M |
| Revenue (Quarterly) | 385.38M |
| Total Expenses (Quarterly) | 338.04M |
| Enterprise Value | 12.94B |
| Gross Profit Margin (Quarterly) | 66.88% |
| Profit Margin (Quarterly) | 12.28% |
| Earnings Yield | 1.34% |
| Operating Earnings Yield | 1.43% |
| Normalized Earnings Yield | 1.338 |